| Literature DB >> 35496060 |
Julia Montenegro1,2, Otniel Freitas-Silva1,3, Anderson Junger Teodoro1.
Abstract
Prostate cancer (PCa) is one of the most common types of cancer among men, and coffee is associated with a reduced risk of developing PCa. Therefore, we aim to review possible coffee molecular mechanisms that contribute to PCa prevention. Coffee has an important antioxidant capacity that reduces oxidative stress, leading to a reduced mutation in cells. Beyond direct antioxidant activity, coffee stimulates phase II enzymatic activity, which is related to the detoxification of reactive metabolites. The anti-inflammatory effects of coffee reduce tissue damage related to PCa development. Coffee induces autophagy, regulates the NF-κB pathway, and reduces the expression of iNOS and inflammatory mediators, such as TNF-α, IL-6, IL-8, and CRP. Also, coffee modulates transcriptional factors and pathways. It has been shown that coffee increases testosterone and reduces sex hormone-binding globulin, estrogen, and prostate-specific antigen. Coffee also enhances insulin resistance and glucose metabolism. All these effects may contribute to protection against PCa development.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35496060 PMCID: PMC9054433 DOI: 10.1155/2022/3254420
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Effects of coffee or coffee compound in vitro, on cell, animal, or epidemiological models.
| Model | Coffee sample/compound | Outcomes | Reference |
|---|---|---|---|
|
| Green and roasted | (-) Hydroxyl (OH°) radicals DNA damage | [ |
|
| Coffee phenolics and caffeine metabolites | (-) DNA single-strand breaks | [ |
| LNCaP, LNCaP-SF, PC-3, and DU145 cells | Kahweol, cafestol, caffeine, caffeic acid, CGA, and trigonelline | (-) Proliferation and migration of PCa cells | [ |
| Xenograft study of SCID mice | (-) PCa growth | ||
| PC-3 cells | Dark roasted | (-) NF- | [ |
| PC-3 xenografts in athymic nude mice | |||
| MC3T3-E1 cells | CGA | (-) H2O2 damage | [ |
| B16F10 cells |
| (-) PI3K/Akt and MAPK | [ |
| AML-12 cells |
| (+) GSH | [ |
| RAW 264.7 cells | (-) TNF- | ||
| RAW 267.4 cells | SCG | (-) NO production | [ |
| CCD-18Co cells | Phenolic compounds from green coffee | (-) ROS production | [ |
| HepG2 and KYSE70 cells | Decaffeinated commercial coffee | (+) UGT | [ |
| RINm5F and 3T3-L1 cells | CGA | (+) Insulin secretion | (Sanchez et al. 2017) |
| EA.hy926 cells | Green and light roast | (+) Redox status | [ |
| Caco-2 cells | Turkish, filter, and instant coffee | (+) AhR and Nrf2 | [ |
| HT29 cells | Blend of green and roasted | (+) Nrf2 transcription and translocation | [ |
| HT29 cells |
| (+) Nrf2 translocation | [ |
| HeLa cells | SCG extracts | (-) ROS level | [ |
| U-937 cells | SCG | (-) TNF- | [ |
| SH-SY5Y | Kahweol | (-) ROS and RNS | (de [ |
| HCT116 | Caffeic acid | (+) Regulation of PI3K/Akt | [ |
| MCF-7, MDA-MB-231, T47D, and Tam-R cells | Caffeine and caffeic acid | (-) ER abundance | [ |
| C57BL/6 mice |
| (-) Liver necrosis | [ |
| C57BL/6 mice | Low-molecular-weight from regular and decaffeinated | (-) MicroRNA-124-3p | [ |
| C57BL/6 mice | Regular and decaffeinated coffee | (+) Autophagic flux | [ |
| HtgUGT1A mice | Caffeic acid | (+) UGT | [ |
| Sprague Dawley rats |
| (-) PSA | (Cueto et al. 2016) |
| Him-OFA rats | Regular and decaffeinated | (-) Hepatic foci frequency | [ |
| Wistar rats | A medium roast of | (+) SOD, CAT, and GPx | [ |
| Wistar rats | Green | (-) Lipid peroxidation | [ |
| Wistar rats | Green | (-) Carrageenan-induced paw oedema | (Pergolizzi et al. 2018) |
| Wistar rats | Green | (-) IL-1 | [ |
| Humanized SHBG transgenic mice | Caffeine | (+) Hepatic SHBG production | [ |
| Cross-sectional clinical trial | Caffeinated beverages | Coffee consumption positively associated with SHBG concentration | [ |
| Prospective clinical trial | Caffeinated and decaffeinated coffee | (-) CRP, IL-6, and TNFR-2 | [ |
| Prospective clinical trial | Coffee intake | (-) Urinary 8-OHdG | [ |
| Prospective clinical trial | Coffee intake | (+) AhR | [ |
| Intervention clinical trial | Green and roasted | (-) Spontaneous DNA strand breaks | ([ |
| Intervention clinical trial |
| (-) DNA strand breaks | [ |
| Intervention clinical trial | Caffeinated and decaffeinated coffee | (+) Insulin sensitivity | [ |
Legend: (-) = reduction/inhibition; (+) = increase/activation/improvement; CGA = chlorogenic acid; SCG = spent coffee ground.
Figure 1Mechanism of coffee's antioxidant activity.
Figure 2Mechanism of action of coffee for anti-inflammatory activity.
Figure 3Mechanism of action of coffee for protection against DNA damage.
Figure 4Mechanism of action of coffee for modulation of transcriptional factors.
Figure 5Mechanism of action of coffee for controlling steroid metabolism.
Figure 6Coffee's mechanism for enhancing insulin resistance.